New Local SEO Services Offered by CLARIO SEO LLC Charlotte, United States – January 1, 2026 / CLARIO SEO LLC / CLARIO SEO LLC has officially launched a new suite of local SEO services designed to ...
Drug research is changing and there are opportunities for growth, says Christopher Fikry, the new CEO of clinical trial tech firm Clario. Fikry, who Clario named as its new chief last month, shared ...
Thermo Fisher Scientific, already a big player in providing services to the biopharmaceutical industry, is adding to its technology capabilities with the $9 billion acquisition of clinical trial ...
PHILADELPHIA, March 17, 2025 /PRNewswire/ -- Clario, a leading provider of endpoint data solutions to the clinical trial industry, today announced they have acquired NeuroRx, a leader in imaging ...
In recent days, Thermo Fisher Scientific has moved closer to its upcoming January 29, 2026 fourth-quarter and full-year 2025 ...
Thermo Fisher Scientific is breaking out the big bills to score a clinical research treat. With $8.875 billion in cash, the life science giant is adding Clario Holdings to its goodie bag, the company ...
(Reuters) - Thermo Fisher said on Wednesday it would buy privately held data management company Clario for up to $9.4 billion, strengthening its clinical trial research business amid a strong rebound ...
Data security is one of the highest priorities when managing clinical trials. Clario's new Federated Identity Management (FIM) System means clients now have the option to use their own trusted login ...
Hosted on MSN
Thermo Fisher to buy Clario for ~$8.9B plus earnouts
Thermo Fisher Scientific (NYSE:TMO) has confirmed a deal to acquire clinical trial data management firm Clario Holdings from a shareholder group led by Astorg and Nordic Capital, Novo Holding, and ...
The fusion of Clario's innovative endpoint technologies and CellCarta's sample management expertise offers a single-vendor solution for imaging and histopathology in clinical trials, advancing ...
In a major private equity buy-out deal, life science giant Thermo Fisher Scientific will pay up to $9.4bn cash to acquire drug trial data software company Clario. The acquisition will give ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback